| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |